A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was the impact of modified ultrafiltration on adult patients undergoing cardiac surgery in terms of inflammatory and metabolic changes, blood loss and early clinical outcomes. A total of 155 papers were identified using the search as described below. Of these, six papers presented the best evidence to answer the clinical question as they reported data to reach conclusions regarding the issues of interest for this review. The author, date and country of publication, patient group, study type and weaknesses and relevant outcomes were tabulated. Modified ultrafiltration in adult patients undergoing cardiac surgery seems to attenuate the levels of inflammatory molecules associated with surgery, reduces blood loss and blood transfusion and improves cardiac output, index and systemic vascular resistance. However, this was not translated in any reduction in length of stay in intensive care unit or hospital. Most studies were single-centre prospective non-blinded trials that included a small cohort of elective coronary artery bypass grafting patients, which makes it underpowered to provide unbiased evidence regarding clinical outcomes. Properly designed and conducted prospective randomized studies are required to answer whether the beneficial effect of modified ultrafiltration on systemic inflammatory molecules associated with surgery can translate with improvement in clinical outcome.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION
In adult patients undergoing [ 
CLINICAL SCENARIO
A 75-year old male patient is undergoing isolated coronary artery bypass on-pump. In theatre, the perfusionist suggests using modified ultrafiltration at the end of the operation. You are not aware of evidence supporting the use of this technique in adult patients so you carry out a literature search. 
SEARCH STRATEGY
Medline
SEARCH OUTCOME
A total of 155 papers were found using the reported search. Of these, six papers provided the best evidence to answer the question. These are presented in Table 1 . Outcomes: Overall hospital mortality was 10% (n = 5) and was lower, But not significantly in the MUF group (MUF: 8%, n = 2 vs control group: 12%, n = 3, P = 0.1)
No differences were observed in terms of the incidence of surgical re-exploration for bleeding (P = 1.0) or the incidence of wound infection (P = 0.15) or the incidence of acute renal failure (P = 1.0)
The duration of ICU and hospital stays did not differ (ICU stay: 5.7 ± 9.21 days in the control group vs 5.1 ± 6.45 in the MUF group, P = 0.25, hospital stay: 12.2 ± 6.5 days in the control group vs 13.4 ± 9.27 days in the MUF group, P = 0.18) Small prospective non-blinded study
The group presenting data on high-risk patients (mean logistic EuroSCORE II: 17.5-%)
The group report that these patients underwent complex cardiac operations but no further details about the nature of these operations Normovolemic MUF of 3000 ml was performed after weaning from CPB Comprehensive data presented, however, the primary outcomes were plasma levels of LBP, terminal complement complex (C5b9) and cytokines so data regarding secondary outcomes may be affected by the small numbers in the study (underpowered) Similar trend was noted for soluble tumour necrosis factor receptor at 48 h (P < 0.001)
Continued
Haematocrit level was higher in the MUF group at the end of bypass (37.8% ± 1.1 vs 34.1% ± 1.1%; P < 0.05), but the levels became comparable at 48 h
Blood loss: The MUF group had less chest tube drainage after 48 h (598 ± 123 vs 848.0 ± 455 ml; P = 0.04) and less red blood cell transfusions (0.6 ± 0.6 units/patient vs 1.6 ± 1.1 units/patient; P = 0.03)
Outcomes:
No differences noted in SVR (P = 0.79) and cardiac index (P = 0.93)
There were no differences in ICU (P = 0.9) and hospital stay (P = 0.8) 50 patients were operated on using normothermic CPB and 47 patients using hypothermic CPB The normothermic group was subdivided into a group with MUF (n = 30) and a group without MUF (n = 20). The hypothermic group was subdivided into a group with MUF (N = 30) and a group without MUF (n = 17) MUF has minimal effect in normothermia MUF can be effective in removing cytokines and adhesion molecules. However, there is no significant impact of MUF on outcomes after elective CABG Inflammatory and metabolic changes:
-After normothermic CPB, soluble E-selectin peaked after 24 h (mean 193 ± 93 ng/ml) in the patient group not undergoing MUF. The difference after 24 h in the patients with MUF was 35% (P < 0.007). No changes were seen after 48 h and 6 days. Soluble ICAM-1 levels in patients with MUF and without MUF differed between 5 and 10%
The study included MUF groups as a subanalysis of two groups of patients who underwent either normothermic or hypothermic CPB
The study looked in detail at different inflammatory mediators
The study is underpowered to detect differences in outcomes between subgroups No changes noted in IL-6 or IL-8
Continued
-After hypothermic CPB, MUF was associated with lowered soluble E-selectin, which decreased by 37% 24 h postoperatively from mean 302.1 ± 123.9 to 191.7 ± 184.4 ng/ml (P = 0.0063), by 40% 48 h postoperatively from mean 241.8 ± 98.9 to 150.3 ± 137.9 ng/ml (P < 0.0027) After 6 days, E-selectin levels were almost reduced to baseline from mean 146.2 ± 62.5 to 98 ± 73.5 ng/ml (P < 0.0084) Soluble ICAM-1 reduced by MUF after 24 h with a reduction of 43% from mean 575.9 ± 212.9 to 333.5 ± 143.8 ng/ml (P < 0.0001), by 44% after 48 h from 675.7 ± 269.7 to 383.6 ± 123.9 (P < 0.0001) and by 60% from 553.5 ± 26.9 to 232.2 ± 153.4 ng/ml (P < 0.0001) 6 days postoperatively
Interleukin-6 levels decreased by 60% from mean 792.9 ± 580.4 to 318.4 ± 393.4 ng/l (P < 0.0018). After 48 h and 6 days changes in IL-6 after MUF were noticeable, but not statistically significant Similar results were noted with IL-8 after 24 h (P < 0.0004) and in TNF-α after 24 h (P < 0.0003) without significance after 48 h or 6 days Blood loss: No differences between the two groups (no P-value)
Outcomes: There were no differences in the clinical variables such as inotropic support, length of intubation and ICU and hospital stay between groups (no P-values)
Onoe et al. (2001) , Perfusion, Japan [7] Case control (level 4) N = 18 patients June 1996 to June 1997 9 patients who underwent different cardiac surgery with CPB and MUF were compared MUF has beneficial effects on postoperative haemodynamics, and can reduce serum IL-8 levels in adult cardiac surgery Inflammatory and metabolic changes: In the MUF group, serum IL-8 was reduced from 69.5 ± 33.5 to 58.9 ± 32.4 pg/ml after MUF (P = 0.0029), whereas it was not reduced in Small study that compared with groups of patients Results presented can be biased considering that the groups compared did not Continued postoperative chest tube drainage was significantly lower in the MUF group at 24 h [mean: 890 (range: 500/1100) ml vs mean: 1075 (range: 800/1413) ml; P = 0.039] and 48 h [mean: 900 (range: 550/1350) ml vs mean: 1400 (range: 900/1750) ml; P = 0.026] postoperatively. The study showed no significant changes with regard to cardiac index or systemic vascular resistance index (SVRI) at end of operation or 6 h later. The incidence of surgical re-exploration for bleeding or acute renal failure did not differ among groups. Similarly, no differences noted in intensive care unit (ICU) or hospital stay. Torina et al. [3] randomized 60 patients undergoing coronary artery bypass grafting (CABG) to either MUF (n = 30) or control (n = 30). The study showed that the MUF group had reduced chest tube drainage after 48 h (598 ± 123 ml vs 848.0 ± 455 ml; P < 0.04) and required less blood transfusion (0.6 ± 0.6 units/patient vs 1.6 ± 1.1 units/patient; P < 0.03). Haematocrit levels were higher in the MUF group than in the control group at the end of bypass (37.8% ± 1.1 vs 34.1% ± 1.1%; P < 0.05). Plasma levels of intercellular adhesion molecule-1 (ICAM-1) were higher in the MUF group than in the control group, particularly in the first sampling (P < 0.01). Plasma levels of soluble tumour necrosis factor receptor were higher in the MUF group than in the control group at 48 h. In this RCT, haemodynamic and oxygen transport parameters were similar in both groups throughout the observation period with no differences in clinical outcomes. These results expanded and confirmed previous observations by the same group in an earlier prospective RCT of 37 patients who underwent CABG [4] .
The design and primary end point investigated in the studies above, however, meant that they are underpowered to detect differences in clinical outcomes.
Boga et al. [5] in an RCT of 40 patients undergoing CABG divided equally into two groups found that haemodynamic parameters and immune mediator levels did not differ between the two groups during the course of the study, except in the immediate postoperative periods, where cardiac output and cardiac index values were significantly greater in the MUF group (5.32 ± 0.91/ min vs 4.42 ± 0.83/min, P = 0.004, and 3.0 ± 0.47/min/m 2 vs 2.30 ± 0.46/min/m 2 , P < 0.0001, respectively) in the early postoperative period. Systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) were significantly greater in the MUF group in the early postoperative period (1635.05 ± 619.9 dyn s/cm 5 5 , respectively; P < 0.001). The result of this study suggests however, that such early improvement of haemodynamic is related to haemoconcentration only after MUF.
Grünenfelder et al. [6] in an RCT that compared MUF under normo-or hypothermic cardiopulmonary bypass (CPB), showed that MUF has minimum impact under normothermic conditions. In this group, MUF was associated with a 35% reduction in E-selectin levels after 24 h (P < 0.007) with no significant changes 48 h or 6 days postoperatively. There were mild changes in soluble ICAM-1 levels (5-10%) favouring MUF with no significant changes in IL-6 or IL-8. More pronounced modifications were noted when using hypothermic CPB. In this group, MUF was associated with a 37% reduction in soluble E-selectin 24 h postoperatively favouring MUF (P = 0.0063). These changes continued to be significant 48 h (P < 0.0027) and even 6 days postoperatively (P < 0.0084). Soluble ICAM-1 levels were altered significantly by MUF with a reduction of 43% after 24 h (P < 0.0001), 44% after 48 h (P < 0.0001) and 60% (P < 0.0001) 6 days postoperatively. IL-6 levels decreased by 60% 24 h post-surgery in the MUF group (P < 0.0018). Similar results were noted with IL-8 (P < 0.0004) and in tumour necrosis factor alpha (P < 0.0003) after 24 h. However, no significant differences in the clinical variables such as inotropic support, length of intubation and ICU and hospital stay were noted. 
